University of Turin, Italy

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Turin, Italy sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

University of Turin, Italy: 1 sponsored US clinical trial, 1 recruiting.

University of Turin, Italy sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Airway Complication of Anesthesia, with 1 trials.

Mid-pack sponsor footprint

University of Turin, Italy is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

NCT05759299

Therapeutic Areas

Airway Complication of Anesthesia 1

What is open in the University of Turin, Italy pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Airway Complication of Anesthesia (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Turin, Italy: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

University of Turin, Italy sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share University of Turin, Italy1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
University of Turin, Italy sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Turin, Italy sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Turin, Italy page

1 registered trials is a research-attention snapshot, not an endorsement of University of Turin, Italy or any single study.

  • 1 of University of Turin, Italy's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Airway Complication of Anesthesia is the condition University of Turin, Italy studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Airway Complication of Anesthesia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Turin, Italy pipeline card: 1 registered trials from official public datasets.Report a data error.